Cationic lipids activate cellular cascades. Which receptors are involved?

[1]  HumphriesMJ HumphriesJD.  CD14 is a ligand for the integrin alpha4beta1. , 2007 .

[2]  A. Hermetter,et al.  Oxidized phospholipids: emerging lipid mediators in pathophysiology , 2008, Current Opinion in Lipidology.

[3]  R. Schumann,et al.  The role of lipopolysaccharide-binding protein in modulating the innate immune response. , 2006, Microbes and infection.

[4]  H. Hydén,et al.  A receptor for phosphatidylserine-speci ® c clearance of apoptotic cells , 2000 .

[5]  B. Czerniecki,et al.  Reengineering dendritic cell‐based anti‐cancer vaccines , 2008, Immunological reviews.

[6]  J. Ruysschaert,et al.  Formation and intracellular trafficking of lipoplexes and polyplexes. , 2005, Molecular therapy : the journal of the American Society of Gene Therapy.

[7]  Leaf Huang,et al.  Reactive oxygen species play a central role in the activity of cationic liposome based cancer vaccine. , 2008, Journal of controlled release : official journal of the Controlled Release Society.

[8]  Simon C Watkins,et al.  Dynamic changes in the characteristics of cationic lipidic vectors after exposure to mouse serum: implications for intravenous lipofection , 1999, Gene Therapy.

[9]  D. Persing,et al.  Structure-Activity Relationship of Synthetic Toll-like Receptor 4 Agonists* , 2004, Journal of Biological Chemistry.

[10]  Tomoko Nakamura,et al.  Cationic liposomes induce apoptosis through p38 MAP kinase–caspase‐8–Bid pathway in macrophage‐like RAW264.7 cells , 2006, Journal of leukocyte biology.

[11]  J. Gatot,et al.  DiC14‐amidine cationic liposomes stimulate myeloid dendritic cells through Toll‐like receptor 4 , 2008, European journal of immunology.

[12]  D. Hammer,et al.  Integrin-mediated signalling through the MAP-kinase pathway. , 2008, IET systems biology.

[13]  Leaf Huang,et al.  Mechanism of adjuvant activity of cationic liposome: phosphorylation of a MAP kinase, ERK and induction of chemokines. , 2007, Molecular immunology.

[14]  M. Koch,et al.  Biological activities of lipopolysaccharides are determined by the shape of their lipid A portion. , 2000, European journal of biochemistry.

[15]  D. Porteous,et al.  Non-viral vectors in cystic fibrosis gene therapy: progress and challenges. , 2004, Trends in biotechnology.

[16]  E. Goetzl,et al.  Lysophospholipids and their G protein-coupled receptors in inflammation and immunity. , 2002, Biochimica et biophysica acta.

[17]  Á. Catala.  Lipid peroxidation of membrane phospholipids generates hydroxy-alkenals and oxidized phospholipids active in physiological and/or pathological conditions. , 2009, Chemistry and physics of lipids.

[18]  A. Chaudhuri,et al.  Cationic liposomes as non‐viral carriers of gene medicines: Resolved issues, open questions, and future promises , 2007, Medicinal research reviews.

[19]  K. Linton,et al.  Cd36, a class B scavenger receptor, functions as a monomer to bind acetylated and oxidized low‐density lipoproteins , 2007, Protein science : a publication of the Protein Society.

[20]  J. Ruysschaert,et al.  Vaccination with the recombinant allergen ProDer p 1 complexed with the cationic lipid DiC14-amidine prevents allergic responses to house dust mite. , 2005, Molecular therapy : the journal of the American Society of Gene Therapy.

[21]  J. Ruysschaert,et al.  Cationic lipids involved in gene transfer mobilize intracellular calcium , 2007, Molecular membrane biology.

[22]  A. Legat,et al.  Free diC14-amidine liposomes inhibit the TNF-α secretion induced by CpG sequences and lipopolysaccharides: role of lipoproteins , 2006, Molecular membrane biology.

[23]  T. Hla,et al.  Lysophospholipids--Receptor Revelations , 2001, Science.

[24]  S. Hazen.  Oxidized Phospholipids as Endogenous Pattern Recognition Ligands in Innate Immunity* , 2008, Journal of Biological Chemistry.

[25]  E. Agger,et al.  Cationic liposomes as vaccine adjuvants , 2007, Expert review of vaccines.

[26]  R. Jerala.  Structural biology of the LPS recognition. , 2007, International journal of medical microbiology : IJMM.

[27]  K. Urabe,et al.  Role of c-Jun N-terminal kinase on lipopolysaccharide induced maturation of human monocyte-derived dendritic cells. , 2004, International immunology.

[28]  C. R. Middaugh,et al.  The Potential Role of Proteoglycans in Cationic Lipid-mediated Gene Delivery , 2001, The Journal of Biological Chemistry.

[29]  Wenjun Guo,et al.  Integrin signalling during tumour progression , 2004, Nature Reviews Molecular Cell Biology.

[30]  Y. Barenholz,et al.  Reversible mode of binding of serum proteins to DOTAP/cholesterol Lipoplexes: a possible explanation for intravenous lipofection efficiency. , 2005, Human gene therapy.

[31]  K. Fukudome,et al.  Comparison of Lipopolysaccharide-Binding Functions of CD14 and MD-2 , 2005, Clinical Diagnostic Laboratory Immunology.

[32]  H. Arai,et al.  SRB1, a class B scavenger receptor, recognizes both negatively charged liposomes and apoptotic cells. , 1996, Experimental cell research.

[33]  K. Burridge,et al.  Bidirectional signaling between the cytoskeleton and integrins. , 1999, Current opinion in cell biology.

[34]  A. Rigotti,et al.  The Class B Scavenger Receptors SR-BI and CD36 Are Receptors for Anionic Phospholipids (*) , 1995, The Journal of Biological Chemistry.

[35]  W. Nelson,et al.  Integrin‐mediated calcium signaling and regulation of cell adhesion by intracellular calcium , 1997, BioEssays : news and reviews in molecular, cellular and developmental biology.

[36]  P. Kraulis.  A program to produce both detailed and schematic plots of protein structures , 1991 .

[37]  M. Netea,et al.  Does the shape of lipid A determine the interaction of LPS with Toll-like receptors? , 2002, Trends in immunology.

[38]  V. Bochkov,et al.  Anti-inflammatory properties of lipid oxidation products , 2003, Journal of Molecular Medicine.

[39]  L. Cowart,et al.  Sphingolipids: players in the pathology of metabolic disease , 2009, Trends in Endocrinology & Metabolism.

[40]  Hayyoung Lee,et al.  Crystal Structure of the TLR4-MD-2 Complex with Bound Endotoxin Antagonist Eritoran , 2007, Cell.

[41]  John B. Wong,et al.  Biophysical characterization of an integrin-targeted lipopolyplex gene delivery vector. , 2006, Biochemistry.

[42]  S. Grinstein,et al.  Signaling events in monocytes and macrophages. , 1995, New horizons.

[43]  F. Liu,et al.  Several serum proteins significantly decrease inflammatory response to lipid-based non-viral vectors. , 2008, Molecular therapy : the journal of the American Society of Gene Therapy.

[44]  C. Hou.  New bioactive fatty acids. , 2008, Asia Pacific journal of clinical nutrition.

[45]  A. Legat,et al.  DiC14-amidine confers new anti-inflammatory properties to phospholipids , 2008, Cellular and Molecular Life Sciences.

[46]  S. Homer-Vanniasinkam,et al.  The lectin-like oxidized low-density-lipoprotein receptor: a pro-inflammatory factor in vascular disease. , 2008, The Biochemical journal.

[47]  J. Couchman,et al.  Regulation of cytoskeletal organization by syndecan transmembrane proteoglycans. , 2003, Matrix biology : journal of the International Society for Matrix Biology.

[48]  E A Merritt,et al.  Raster3D: photorealistic molecular graphics. , 1997, Methods in enzymology.

[49]  D. Maskell,et al.  Elucidation of the MD-2/TLR4 Interface Required for Signaling by Lipid IVa1 , 2008, The Journal of Immunology.

[50]  N. Gay,et al.  Structure and function of Toll receptors and their ligands. , 2007, Annual review of biochemistry.

[51]  J. Madrenas,et al.  Polycationic lipids inhibit the pro-inflammatory response to LPS. , 2005, Immunology letters.

[52]  A. Woods,et al.  Syndecan proteoglycans and cell adhesion. , 1998, Matrix biology : journal of the International Society for Matrix Biology.

[53]  M. Humphries,et al.  CD14 is a ligand for the integrin α4β1 , 2007 .

[54]  Evi Kostenis,et al.  Novel clusters of receptors for sphingosine‐1‐phosphate, sphingosylphosphorylcholine, and (lyso)‐phosphatidic acid: New receptors for “Old” ligands , 2004, Journal of cellular biochemistry.

[55]  M. Lensink,et al.  Characterization of the cationic DiC(14)-amidine bilayer by mixed DMPC/DiC(14)-amidine molecular dynamics simulations shows an interdigitated nonlamellar bilayer phase. , 2009, Langmuir : the ACS journal of surfaces and colloids.

[56]  Yusuf A. Hannun,et al.  Principles of bioactive lipid signalling: lessons from sphingolipids , 2008, Nature Reviews Molecular Cell Biology.

[57]  V. Brinkmann.  Sphingosine 1-phosphate receptors in health and disease: mechanistic insights from gene deletion studies and reverse pharmacology. , 2007, Pharmacology & therapeutics.

[58]  L. Kline,et al.  Cell Activation Mediated by Glycosylphosphatidylinositol-Anchored or Transmembrane Forms of CD14 , 1998, Infection and Immunity.

[59]  J. Behr,et al.  A model for non‐viral gene delivery: through syndecan adhesion molecules and powered by actin , 2004, The journal of gene medicine.

[60]  Y. Satow,et al.  Crystal Structures of Human MD-2 and Its Complex with Antiendotoxic Lipid IVa , 2007, Science.

[61]  G. Besra,et al.  Serum lipids regulate dendritic cell CD1 expression and function , 2008, Immunology.

[62]  D. Hwang,et al.  The modulation of inflammatory gene expression by lipids: mediation through Toll-like receptors. , 2006, Molecules and cells.

[63]  Leaf Huang,et al.  Immunostimulation of dendritic cells by cationic liposomes , 2006, Molecular membrane biology.

[64]  A. Dackiw,et al.  VLA-4 Integrin Cross-linking on Human Monocytic THP-1 Cells Induces Tissue Factor Expression by a Mechanism Involving Mitogen-activated Protein Kinase* , 1997, The Journal of Biological Chemistry.

[65]  M. Yazdanbakhsh,et al.  Control of inflammatory diseases by pathogens: lipids and the immune system , 2003, European journal of immunology.

[66]  M. Muroi,et al.  Structural Regions of MD-2 That Determine the Agonist-Antagonist Activity of Lipid IVa* , 2006, Journal of Biological Chemistry.

[67]  I. Campbell,et al.  Transmembrane and cytoplasmic domains in integrin activation and protein-protein interactions (Review) , 2008, Molecular membrane biology.

[68]  B. Levy,et al.  Lipid mediators as agonists for the resolution of acute lung inflammation and injury. , 2007, American journal of respiratory cell and molecular biology.

[69]  D. Hoekstra,et al.  Cationic lipids, lipoplexes and intracellular delivery of genes. , 2006, Journal of controlled release : official journal of the Controlled Release Society.

[70]  Zhengfan Jiang,et al.  CD14 is required for MyD88-independent LPS signaling , 2005, Nature Immunology.

[71]  G. Robillard,et al.  Adhesion receptors mediate efficient non-viral gene delivery. , 2007, Molecular therapy : the journal of the American Society of Gene Therapy.

[72]  J. Ruysschaert,et al.  Cationic liposomal lipids: from gene carriers to cell signaling. , 2008, Progress in lipid research.

[73]  J. Weckesser,et al.  Influence of the supramolecular structure of free lipid A on its biological activity. , 1993, European journal of biochemistry.

[74]  E. Brambilla,et al.  An electron microscopy study into the mechanism of gene transfer with lipopolyamines. , 1996, Gene therapy.

[75]  K. Mislick,et al.  Evidence for the role of proteoglycans in cation-mediated gene transfer. , 1996, Proceedings of the National Academy of Sciences of the United States of America.

[76]  R. Schumann,et al.  Non-LPS targets and actions of LPS binding protein (LBP) , 2005, Journal of endotoxin research.

[77]  J. Ruysschaert,et al.  Identification of human plasma proteins that bind to cationic lipid/DNA complex and analysis of their effects on transfection efficiency: implications for intravenous gene transfer. , 2003, Molecular therapy : the journal of the American Society of Gene Therapy.

[78]  R. Haring,et al.  Bioactive lipids and their receptors. , 2002, Current opinion in drug discovery & development.

[79]  J. Sepulveda,et al.  Assembly and signaling of adhesion complexes. , 2005, Current topics in developmental biology.

[80]  N. Gay,et al.  MD-2: the Toll 'gatekeeper' in endotoxin signalling. , 2004, Trends in biochemical sciences.